Expression of a putative immunosuppressive protein in human tumors and tissues

Pathobiology

Volumn 64, Issue 5, 1996, Pages 233-238

  Turbeville, Michael A ^a   Rhodes, Judith C ^a   Hyams, David M ^a   Distler, Carole M ^a   Steele, Paul E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Envelope; Human endogenous; Immunosuppression; p15E; Retrovirus

Indexed keywords

ANTISERUM; HYBRID PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; ENVELOPE GENE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT; RETROVIRUS; TISSUE DISTRIBUTION;

EID: 0030513866     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164053     Document Type: Article

References (27)

1. Cianciolo GJ: Anti-inflammatory effects of neoplasia: in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York. Raven Press. 1988. pp 861-874.
2. Kehrl JH, Alverez-Mon M, Fauci AS: Type B transforming growth factor suppresses the growth and differentiation of human B and T lymphocytes. Clin Res 1985;33:610A.
3. Rook AH, Kehri JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS: Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986:136: 3916-3920.
4. Kehrl JH, Wakefield IM, Roberts AB, Jakow-lew S, Alvarez-Mon M, Derynck R, Spom MB, Fauci AS: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-1050.
5. 2. J Immunol 1994:153:1674-1686.
6. Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL, Royston I, Sobol RE: Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc Natl Acad Sei 1996:93:2909-2914.
7. Brunda MJ, Herberman RB, Holden HT: Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 1980:124:2682-2687.
8. Young MR, Knies S: Prostaglandin E production by Lewis lung carcinoma: Mechanism for tumor establishment in vivo. J Natl Cancer Inst 1984:72:919-922.
9. Gasll GA, Abrams JS, Nanus DM, Ooster-kamp R, Silver J, Liu F, Chen M, Albino AP, Bander NH: Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 1993:55: 96-101.
10. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993:11:165-190.
11. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uvemura K: IL-10 production in cutaneous basal and squamous cell carcinomas: A mechanism for evading the local T cell immune response. J Immunol 1995: 155:2240-2247.
12. Cianciolo GJ, Matthews TJ, Bolognesi DP, Snyderman R: Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol 1980:124:2900-2905.
13. Snyderman R, Cianciolo GJ: Immunosuppressive activity of the retroviral envelope protein P15E and its possible relationship to neoplasia. Immunol Today 1984:5:240-244.
14. Cohen M, Larsson E: Human endogenous retroviruses. Bioassays 1988:9:191-196.
15. Larsson E, Kato N, Cohen M: Human Endogenous Retroviruses. Current Topics in Microbiology and Immunology. Heidelberg. Springer, 1989. pp 115-132.
16. Rabson AB, Steele PE, Repaske R, Martin MA: Structure and function of human endogenous type C retroviral DNAs: in Furmanski P. Hager JC. Rich MA (eds): RNA Tumor Viruses. Oncogenes, Human Cancer and AIDS: On the Frontiers of Understanding. New York. Nijhoff, 1985. pp 93-107.
17. Respaske R, Steele PE, O'Neill RR, Rabson AB, Martin MA: Nucleotide sequence of a full-length human endogenous retroviral segment. J Virol 1985:54:764-772.
18. O'Connell C, O'Brien S, Nash W, Cohen M: ERV 3, a full-length human endogenous provirus: Chromosomal localization and evolutionary relationships. Virology 1984;138:225-235.
19. Ono M, Yasunaga T, Miyata T, Ushikubo H: Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol 1986:60:589-598.
20. Cohen M. Powers M, O'Connell C. Kato N: The nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology 1985:147:449-458.
21. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R: Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985:230: 453-455.
22. Cianciolo GJ, Lostrom ME, Tam M, Snyderman R: Murine malignant cells synthesize a 19.000-dalton protein physicochemically and antigenically related to the immunosuppressive retroviral protein PI5E. J Exp Med 1983:158: 885-900.
23. Cianciolo GJ, Hunter J, Silva J, Haskill JS, Snyderman R: Inhibitors of monocyte responses to chcmotaxins arc present in human cancerous effusions and react with monoclonal antibodies to the P15E structural protein of retroviruses. J Clin Invest 1981:68:831-844.
24. Cianciolo GJ, Phipps D, Snyderman R: Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen. J Exp Med 1984:159:964-969.
25. Tan IB, Drexhage HA, Scheper RJ, von Blomberg van de Flier M, de Haan-Meulman M, Snow GB, Balm FJM: Immunosuppressive retroviral P15E-relatcd factors in head and neck carcinomas. Arch Otolaryngol Head Neck Surg 1986:112:942-945.
26. Sasaki T: Integration and expression of human endogenous retrovirus. Hokkaido J Med Sci 1991;66:794-803.
27. Venables PJW, Brookes SM, Griffiths D, Weiss RA, Boyd MT: Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology 1995:211:589-592.